`
`
`
`
`.
`Mail Stop 3
`,
`REPORT ON THE
`TO'
`Director of the US. Patent and Trademark (it iggjgfiggfifiv
`OR DETERMINATION OF AN
`
`
`
`P.O. Box 1450
`ACTION REGARDING A PATENT 0R
`
`
`
`Alexandria, VA 22313-1450
`TRADEMARK
`
`
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`
`Northern District of West Virginia
`
`filed in the US District Court
`
`on the following
`
`[:1 Trademarks or
`
`MPatents.
`
`( E] the patent action involves 35 U.S.C. § 292.):
`
`DATE FILED
`4/12/2017
`
`DOCKET NO.
`U.S. DISTRICT COURT
`
`
`'
`Northern District of West Vir- inia
`PLAINTIFF
`DEFENDANT
` Bristol-Myers Squibb Company and Pfizer Inc.
`
`Mylan Pharmaceuticals inc.
`
`
`
`
`PATENT OR
`TRADEMARK N0.
`
`DATE OF PATENT
`OR TRADEMARK
`
`HOLDER OF PATENT OR TRADEMARK
`
`1 US 6,967,208 82
`
`11/22/2005
`
`Bristol-Myers Squibb Company
`
`2 US 9,326,945 82
`
`5/3/2016
`
`Bristol-Myers Squibb Company and Pfizer inc.
`
`_—_
`———
`—_—
`
`
`
`
`
`
`
`
`
`
`DATE INCLUDED
`
`In the above—entitled case, the following patent(s)/ trademark(s) have been included:
`INCLUDED BY
`
`PATENT OR
`TRADEMARK NO.
`
`l
`
`E] Amendment
`DATE OF PATENT
`OR TRADEMARK
`
`I:I Answer
`
`I:I Cross Bill
`
`[:1 Other Pleading
`
`HOLDER OF PATENT OR TRADEMARK
`
`
`
`
`
`_-—
`--_
`
` —_—
`
`-—_
`--_
`(BY) DEPUTY CLERK
`
`In the above—entitled case, the following decision has been rendered or judgement issued:
`DECISION/JUDGEMENT
`
`Copy l—Upon initiation of action, mail this copy to Director Copy 3——-Upon termination of action, mail this copy to Director
`Copy 2—Upon filing document adding patent(s), mail this copy to Director Copy 4—Case file copy
`
`